Stroke (CVA) or TIA
33
13
16
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.0%
1 terminated out of 33 trials
90.0%
+3.4% vs benchmark
0%
0 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 9 completed trials
Clinical Trials (33)
Emergency Stroke Unit for Acute Cerebrovascular Events: A Prospective, Single-arm Trial With a Historical Control Group
Stroke Care During the COVID-19 Pandemic
Self-Supervised Constraint-Induced Movement Therapy for Stroke Recovery
Pemafibrate for Symptomatic ICAS RCT
Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data
Cawthorne-Cooksey Exercises and Frenkel Exercises on Balance and Coordination in Stroke
Accelerated rTMS for Post-Stroke Apathy
Trunk Impairment Scale - Adaptation and Validation in French
Risk Factors, Costs, and Impacts of ED Boarding
Functional Electrical Stimulation Versus Whole-Body Vibration in Post-Stroke Rehabilitation
Pnf Techniques vs Mirror Therapy
Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation
Comparative Effects of Somatosensory Stimulation and Task Based Mirror Therapy in Post Stroke Patients
NORA-HOME: An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks
Early Functional Proprioceptive Stimulation Post-stroke
Mirror Therapy on Motor Recovery and Pain of Hemiparetic Arm
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System
[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease
Evaluating the Safety and Efficacy of the Maurora® DES in ICAS